Provided by Tiger Trade Technology Pte. Ltd.

Neurocrine Biosciences

150.02
-7.2000-4.58%
Post-market: 150.020.00000.00%19:54 EDT
Volume:1.33M
Turnover:201.49M
Market Cap:15.30B
PE:21.99
High:156.70
Open:156.70
Low:149.15
Close:157.22
52wk High:186.12
52wk Low:122.14
Shares:102.00M
Float Shares:100.00M
Volume Ratio:1.50
T/O Rate:1.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):6.82
EPS(LYR):4.67
ROE:22.09%
ROA:11.70%
PB:4.14
PE(LYR):32.12

Loading ...

Oct 05, 2023

Major Issues Report

Form 8-K - Current report
Oct 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 13, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 12, 2023

Major Issues Report

Form 8-K - Current report
Sep 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 01, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2023

Major Issues Report

Form 8-K - Current report